334 related articles for article (PubMed ID: 8350044)
21. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders.
Witzig TE; Meyers C; Therneau T; Greipp PR
Leuk Lymphoma; 2000 Jul; 38(3-4):345-50. PubMed ID: 10830741
[TBL] [Abstract][Full Text] [Related]
23. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.
Billadeau D; Quam L; Thomas W; Kay N; Greipp P; Kyle R; Oken MM; Van Ness B
Blood; 1992 Oct; 80(7):1818-24. PubMed ID: 1391945
[TBL] [Abstract][Full Text] [Related]
24. Detection of peripheral blood myeloma cells by three-color flow cytometry.
Witzig TE; Kimlinger TK; Greipp PR
Curr Top Microbiol Immunol; 1995; 194():3-8. PubMed ID: 7895502
[No Abstract] [Full Text] [Related]
25. In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression.
Rawstron AC; Barrans SL; Blythe D; English A; Richards SJ; Fenton JA; Davies FE; Child JA; Jack AS; Morgan GJ
Br J Haematol; 2001 Jun; 113(3):794-802. PubMed ID: 11380472
[TBL] [Abstract][Full Text] [Related]
26. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
[TBL] [Abstract][Full Text] [Related]
27. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
Pope B; Brown R; Gibson J; Joshua D
Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
[TBL] [Abstract][Full Text] [Related]
28. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.
Corradini P; Voena C; Astolfi M; Ladetto M; Tarella C; Boccadoro M; Pileri A
Blood; 1995 Mar; 85(6):1596-602. PubMed ID: 7888677
[TBL] [Abstract][Full Text] [Related]
29. Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient.
Bakkus MH; Schots R; Gomez La Fuente PB; Van Riet I; Thielemans K; De Waele M; Van Camp B
Eur J Haematol; 2000 Nov; 65(5):348-55. PubMed ID: 11092467
[TBL] [Abstract][Full Text] [Related]
30. B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.
Rawstron AC; Davies FE; Owen RG; English A; Pratt G; Child JA; Jack AS; Morgan GJ
Br J Haematol; 1998 Jan; 100(1):176-83. PubMed ID: 9450807
[TBL] [Abstract][Full Text] [Related]
31. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.
Pope B; Brown RD; Gibson J; Petersen A; Wiley J; Joshua DE
Leuk Lymphoma; 1997 Sep; 27(1-2):83-91. PubMed ID: 9373199
[TBL] [Abstract][Full Text] [Related]
32. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
33. Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes.
Joshua DE; Ioannidis R; Brown R; Francis SE; Gibson J; Kronenberg H
Am J Hematol; 1988 Sep; 29(1):5-11. PubMed ID: 3052044
[TBL] [Abstract][Full Text] [Related]
34. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
[TBL] [Abstract][Full Text] [Related]
35. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Thiago LS; Perez-Andres M; Balanzategui A; Sarasquete ME; Paiva B; Jara-Acevedo M; Barcena P; Sanchez ML; Almeida J; González M; San Miguel JF; Garcia-Sanz R; Orfao A
Haematologica; 2014 Jan; 99(1):155-62. PubMed ID: 23872308
[TBL] [Abstract][Full Text] [Related]
36. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
Perfetti V; Vignarelli MC; Bellotti V; Glennie MJ; Zorzoli I; Ubbiali P; Obici L; Massa M; Ippoliti G; Ascari E; Merlini G
Lab Invest; 1997 Oct; 77(4):333-44. PubMed ID: 9354768
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
[TBL] [Abstract][Full Text] [Related]
38. Identification of early plasma cells in peripheral blood and their clinical significance.
Harada Y; Kawano MM; Huang N; Mahmoud MS; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
Br J Haematol; 1996 Jan; 92(1):184-91. PubMed ID: 8562394
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
40. The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis.
Joshua D; Petersen A; Brown R; Pope B; Snowdon L; Gibson J
Br J Haematol; 1996 Jul; 94(1):76-81. PubMed ID: 8757512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]